Therapeutic Targeting of the LXR Pathway for Improving Myelin Integrity in Neurodegeneration
- 1Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA
- 2Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA
Abstract
Neurodegenerative and demyelinating diseases are often associated with impaired cholesterol homeostasis, glial dysfunction, neuroinflammation, and impaired myelin maintenance. Because myelin is highly enriched in cholesterol and other lipids, efficient lipid transport, recycling, and availability are essential for oligodendrocyte function and remyelination. Liver X receptors (LXRα and LXRβ) are lipid-sensitive nuclear receptors that connect cholesterol metabolism with glial responses and myelin regulation. In the CNS, the 24S-hydroxycholesterol (24S-OHC)-LXR-ABCA1/ABCG1-ApoE axis serves as an important regulatory pathway for cholesterol efflux, ApoE-mediated lipid redistribution, microglial handling of myelin-derived lipids, and maintenance of cholesterol availability required for oligodendrocyte maturation and myelin formation. The 24S-OHC generated from cholesterol by CYP46A1 acts as an endogenous LXR ligand and promotes transcription of cholesterol efflux genes such as ABCA1 and ABCG1, along with ApoE-mediated lipid transport. Although previous studies with LXR agonists have focused on oligodendrocyte health and remyelination via inflammatory regulation, translation of LXR agonists remains limited by poor CNS exposure, lack of isoform selectivity, and LXRα-mediated hepatic lipogenesis and metabolic toxicity. These limitations have shifted therapeutic development toward LXRβ-biased agonists, CNS-restricted delivery, partial agonism, and modulation of the CYP46A1/24S-OHC pathway. Overall, LXR signaling represents a mechanistic link among brain cholesterol homeostasis, glial lipid handling, and myelin integrity; therefore, the development of next-generation selective LXR agonists offers substantial potential to restore lipid homeostasis and enhance neuroprotection across neurodegenerative diseases.
Related
- Therapeutic Targeting of the TGFβ Pathway Augments CAR T cell Efficacy in Glioblastoma
- AKAP1 Protects Retinal Ganglion Cells and Preserves Vision by Improving Mitochondrial and Synaptic Health in Glaucomatous Neurodegeneration.
- Therapeutic delivery systems need to focus on cellular precision to target neurodegeneration
- Intra-amniotic transplantation of APOM-modified BMSCs facilitates neural repair in spina bifida by improving vascular endothelial integrity.
- Endothelial KLK10 maintains blood-brain barrier integrity and mitigates ischemic stroke by limiting the cGAS-STING pathway.
BibTeX
@article{tamhankar2026therapeutic,
title = {{Therapeutic Targeting of the LXR Pathway for Improving Myelin Integrity in Neurodegeneration}},
author = {Sampada Tamhankar and Meenakshi Singh and Joyal Xavier and Kristine Griffett and Rajesh Amin},
journal = {Cells},
year = {2026},
month = oct,
doi = {10.3390/cells15211928},
url = {https://www.mdpi.com/2073-4409/15/21/1928},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Therapeutic Targeting of the LXR Pathway for Improving Myelin Integrity in Neurodegeneration
AU - Sampada Tamhankar
AU - Meenakshi Singh
AU - Joyal Xavier
AU - Kristine Griffett
AU - Rajesh Amin
PY - 2026
DA - 2026/10/23
JO - Cells
DO - 10.3390/cells15211928
UR - https://www.mdpi.com/2073-4409/15/21/1928
AB - Neurodegenerative and demyelinating diseases are often associated with impaired cholesterol homeostasis, glial dysfunction, neuroinflammation, and impaired myelin maintenance. Because myelin is highly enriched in cholesterol and other lipids, efficient lipid transport, recycling, and availability are essential for oligodendrocyte function and remyelination. Liver X receptors (LXRα and LXRβ) are lipid-sensitive nuclear receptors that connect cholesterol metabolism with glial responses and myelin regulation. In the CNS, the 24S-hydroxycholesterol (24S-OHC)-LXR-ABCA1/ABCG1-ApoE axis serves as an important regulatory pathway for cholesterol efflux, ApoE-mediated lipid redistribution, microglial handling of myelin-derived lipids, and maintenance of cholesterol availability required for oligodendrocyte maturation and myelin formation. The 24S-OHC generated from cholesterol by CYP46A1 acts as an endogenous LXR ligand and promotes transcription of cholesterol efflux genes such as ABCA1 and ABCG1, along with ApoE-mediated lipid transport. Although previous studies with LXR agonists have focused on oligodendrocyte health and remyelination via inflammatory regulation, translation of LXR agonists remains limited by poor CNS exposure, lack of isoform selectivity, and LXRα-mediated hepatic lipogenesis and metabolic toxicity. These limitations have shifted therapeutic development toward LXRβ-biased agonists, CNS-restricted delivery, partial agonism, and modulation of the CYP46A1/24S-OHC pathway. Overall, LXR signaling represents a mechanistic link among brain cholesterol homeostasis, glial lipid handling, and myelin integrity; therefore, the development of next-generation selective LXR agonists offers substantial potential to restore lipid homeostasis and enhance neuroprotection across neurodegenerative diseases.
SN - 2073-4409
ER -